Embark Health Inc. entered into a definitive agreement to acquire Axiomm Technologies Ltd. from MMJ Group Holdings Limited (ASX:MMJ) and others for CAD 0.7 million on August 12, 2020. The deal will be on share for share basis. MMJ Group Holdings has executed documentation to sell its holding in Axiomm Technologies to Embark Health in return for Embark Health shares with a value of CAD 2.44 each for total value of CAD 0.7 million. Axiomm Technologies Ltd. will become a wholly owned subsidiary of Embark Health Inc. Axiomm Technologies staff will operate a 4600 square feet production facility in Calgary AB. Axiomm Technologies Board of Directors recommended that all Axiomm shareholders accepted the Embark Health’s acquisition offer. MMJ Group have also voted in favor of a merger between Embark Health and Axiomm Technologies. Embark Health Inc. completed the acquisition of Axiomm Technologies Ltd. from MMJ Group Holdings Limited (ASX:MMJ) and others on September 11, 2020. Pursuant to the Acquisition, Embark has issued 2,152,257 common shares to the shareholders of Axiomm in exchange for all the issued and outstanding shares of Axiomm. The Axiomm team will remain engaged with Embark Nano to continue the operations of Embark Nano Inc. in addition to taking on expanded roles within the Embark Health organization.